Cipla Shares Traded 1.51% Lower on Inspection by USFDA
Shares of Cipla Ltd. sank 1.51% on a routine current Good Manufacturing Practices (cGMP) inspection conducted by the United States Food and Drug Administration (USFDA)...
Tag : Cipla
Sanofi India and Cipla Shares Trade Higher on Singing a Distribution Agreement
Shares of Sanofi India Ltd and Cipla Ltd were trading 5.4% and 1.6% higher on 27 March after the companies announced signing a distribution agreement...
Cipla Shares Trade Lower on Acquiring Additional Stake in JV
Shares of Cipla were trading in the red on 28 November after its European subsidiary, Cipla EU, acquired an additional stake in its Joint Venture...
Cipla Receives US FDA Letter Flagging Data Issues at MP Unit, Stock Emerges Top Nifty Losers
On November 23, 2023, Cipla, a prominent pharmaceutical company, witnessed a nearly 7% decline in its stock following the issuance of a warning letter by...
Cipla Shares Gain Marginally as Board Approves Sale of Generic Business for Rs 350 Crore
Shares of Cipla were trading in the green on 7 November after the Board of Directors of the company approved the sale of its generic...
Cipla Shares Gain 2% on Strong Q2 Report; Net Profit at Rs 1,131 Crore
Shares of Cipla were trading 2% above on 27 October after the company announced its quarterly earnings for the July-September. The Indian pharma major reported...
Cipla’s Shares in the Red After Subsidiary’s Facility Gets Inspection Report from USFDA
Cipla shares were trading in the red on 12 October after the USFDA (US Food and Drug Administration) inspected the company’s American facility and issued...
Cipla Share Fall 2% After US Subsidiary Receives 5 Observations
Cipla shares fell as much as 2% during the trading session on 21 September after InvaGen Pharmaceuticals, its wholly-owned subsidiary, received 5 inspectional observations from...
FDA Suspends Cipla’s License of Patalganga Unit for 10 Days; Shares Slip 1%
Cipla’s shares are in the limelight today after the Konkan division of the Food and Drug Administration had ordered the suspension of the license issued...
USFDA Finds Regulatory Gaps in Cipla’s Pithampur Facility Inspection: Shares Tumble
Cipla’s Pithampur Manufacturing Facility has received a current Good Manufacturing Practices (cGMP) inspection by the USFDA (the United States Food and Drug Administration) from 6...